Navigation Links
First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA

T) and then Herceptin(R) monotherapy (6 mg/kg every

three weeks) to complete one year of Herceptin(R) treatment

- TCH (n=1.075), the non-anthracycline experimental regimen consisting of

Taxotere(R) (T, 75 mg/m2) plus carboplatin (C; AUC 6 mg/mL/min) every

three weeks for six cycles plus Herceptin(R) (H, 4 mg/kg loading dose

followed by 2 mg/kg per week concurrently with TC) and then Herceptin(R)

monotherapy (6 mg/kg every three weeks) to complete one year of

Herceptin(R) treatment.

The primary endpoint of the study was to compare disease-free survival (DFS) of each of the experimental regimens (TCH or AC-TH) with standard anthracycline-based chemotherapy (AC-T).

Secondary endpoints included evaluation of overall survival (OS) and cardiac toxicity. The first analysis (considered as the primary) was presented at the SABCS in 2006 and the updated results were communicated at SABCS in 2007.

Efficacy results

DFS was significantly improved by one third (33 percent) in the TCH treatment arm (HR=0.67, 95% CI [0.54-0.83], p=0.0003) and 39 percent (HR=0.61, 95% CI [0.49-0.77], p<0.0001) in the AC-TH arm, compared to the AC-T control arm. The DFS benefit of TCH and AC-TH was present regardless of a patient's age, the tumor responsiveness to hormones (hormone receptor status), or whether or not the cancer had spread to lymph nodes (nodal status). There was no statistically significant difference in DFS between the two experimental arms (TCH and AC-TH).

OS was also significantly improved with the TCH regimen with 34% reduction in the risk of death (HR=0.66, 95% CI [0.47-0.93], p=0.0182) compared to the AC-T control arm. Similarly, AC-TH was associated with a 42% reduction in the risk of death (HR=0.58, 95% CI [0.40-0.83], p=0.0024) compared to the AC-T control arm. There was no statistically significant difference in OS between the two experimental arms (TCH and AC-TH).

Tolerance '/>"/>

SOURCE Cancer International Research Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
(Date:10/7/2015)... 7, 2015  ChromaDex Corp. (OTCQX: CDXC), an ... that creates science-based solutions for dietary supplement, food ... products, today announced that the October 1 presentation ... is now available for on-demand viewing at ...   --> LINK: ...
(Date:10/7/2015)... ORANGEBURG, N.Y. , Oct. 7, 2015   ... solutions, today released an infographic that highlights key challenges ... selecting an appropriate disinfectant for the situation. This tool ... around steps hospitals can take to create efficiencies and ... The visual guide emphasizes examples of how ...
(Date:10/7/2015)... RADNOR, Pa. , Oct. 7, 2015   ... global, independent provider of laboratory products, services and ... Technologies Inc. (PTI), a specialty solvent company that ... solvents. This acquisition will enhance VWR,s growing laboratory ... its laboratory and biopharmaceutical manufacturing customers. ...
(Date:10/7/2015)... (PRWEB) , ... October 07, 2015 , ... ... today announced a webinar titled Smart Nanostructured Coatings to provide a comprehensive overview ... Register for this free webinar at . This webinar will be ...
Breaking Biology Technology:
... 5 innovative Essentially products for multiple ... health applications -, - Launch scheduled for April 2008 in ... ... QC, and EAST YORKSHIRE, United Kingdom, April 2,/PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ...
... 2008 ABR-Affinity,BioReagents, a leading global antibody manufacturer, announced ... the 14th Annual Conference and,Exhibition of the Society for ... 2008., "We are extremely pleased to support the ... the SBS meeting, especially as it is a,non-profit forum. ...
... April 2, 2008 /Xinhua-PRNewswire-FirstCall/ -- China,Technology Development ... a provider of clean and renewable energy ... in China, today announced that the,Company attended ... Thin Film,Amorphous Silicon Solar Module manufacturing line ...
Cached Biology Technology:
(Date:9/2/2015)... Security of data and assets has ... organizations, telecommunications, hospitals, as well as individuals. Keys, ... used to prevent unauthorised access. Technological advancements resulted ... could gain access to secure premises after being ... devices and numeric codes. However, hackers also could ...
(Date:9/1/2015)... VIEW, Calif. , Sept. 1, 2015 /PRNewswire/ ... with travelers during airport passenger screening. This is ... the passenger screening process will become unintrusive. An ... pre-clearance based on voluntary background investigations will transform ... from Frost & Sullivan, Global Airport Passenger ...
(Date:8/31/2015)... , Aug. 31, 2015 Research and ... the "Saudi Arabia Biomedical Sensors Market - Growth, ... The Saudi Arabia Biomedical Sensors market ... CAGR of 3.64% over the period 2014-2020 ... adaptable to the genetic formulation of each individual. These ...
Breaking Biology News(10 mins):
... in the Biochemistry and Biophysics Department within the School ... has been awarded the 2012 Paul Ehrlich and Ludwig ... field of cell biology." The 100,000 German ... decades on how cells cope with stressinsight that has ...
... where two millipede species meet has been mapped in northwest ... but the two millipedes cross very little into each other,s ... km long and less than 100 m wide where carefully ... by Dr Bob Mesibov, who is a millipede specialist and ...
...  Rune, an information security firm committed to empowering ... Haggard has been appointed to its Board of ... background in the information security sector. He is ... of advanced state-of-the-art information security products in many ...
Cached Biology News:
... Human IgG Fd. ELISA Specificity: (4) ,human IgG subclass 1 ... ,human IgG subclass 3 100% ,human IgG subclass ... ... 0.04% ,human IgG Fab ...
Human VEGF R2 (KDR) MAb (Clone 89106)...
Salmonella typhimurium Immunogen: Heat inactivated bacterial cells of Salmonella typhimurium B Storage: 4 C...
Biology Products: